1. Bliznakov, E.G., Wilkins, D.J.: Biochemical and clinical consequences of inhibiting coenzyme Q10 biosynthesis by lipid-lowering HMG-CoA reductase inhibitors (statins): a critical overview. Adv. Ther. 5, 218–228 (1998)
2. Crane, F.L., Hatefi, Y., Lester, R.L., Widmer, C.: Isolation of a quinone from beef heart mitochondria. Biochim. Biophys. Acta 25, 220–221 (1957). doi: 10.1016/0006-3002(57)90457-2
3. Eggens, I., Elmberger, P.G., Löw, P.: Polyisoprenoid, cholesterol and ubiquinone levels in human hepatocellular carcinomas. Br. J. Exp. Pathol. 70, 83–92 (1989)
4. Kalen, A., Appelkvist, E.L., Dallner, G.: Age-related changes in the lipid composition of rat and human tissues. Lipids 24, 579–584 (1989). doi: 10.1007/BF02535072
5. Littarru, G.P., Battino, M., Folkers, K.: Clinical aspects of coenzyme Q: improvement of cellular bioenergetics or antioxidant protection? In: Cadenas, E., Packer, L. (eds.) Handbook of antioxidants, pp. 203–239. Marcel Decker, New York (1996)